Article
IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.
Urologia internationalis - 1 Jan 2014
Ding Qi, Shi Ying, Fan Bo, Fan Zhijiang, Wang Jing
Abstract excerpt
OBJECTIVE: Evidence suggests that insulin-like growth factor-binding protein 3 (IGFBP-3) might play a role in the carcinogenesis of prostate cancer (PCa). To date, several studies have been conducted to investigate the association between IGFBP-3 -202A>C polymorphism and PCa risk in humans. However, the results remain inconclusive and inconsistent. Hence, we performed a meta-analysis of all eligible case-control...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
